PPARG and colitis: The results showed that the two PPARγ agonists significantly reduced the levels of 2-HG and H3K4me3 in colons of mice with colitis, regulated the levels of GSH and ROS in lymphocytes of colonic lamina propria, and the effects were weakened by GLS1 overexpression (Figure 8A-D).